[Immunosuppressive therapy in pemphigus vulgaris].
D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D003900:Desoxycorticosterone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010392:Pemphigus / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D014221:Triamcinolone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D014221:Triamcinolone; D003900:Desoxycorticosterone; D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate
Immunsuppressionstherapie bei Pemphigus vulgaris.